Recorded: EpiVax EPV-CoV-19 Vaccine Webinar

by Annie De Groot | Sep 21, 2020 | Events, Webinars

Thank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email...

Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine

by Adam | Jun 2, 2020 | News

Bilthoven, The Netherlands, Providence, R.I., USA, 2 June 2020 –  Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a...

Press Release: Pacific GeneTech Partners With EpiVax on a Novel Vaccine Approach for ASF

by Adam | May 1, 2020 | News

HONG KONG, May 1, 2020 (Newswire.com) – Pacific GeneTech (PGT), a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in animal health and food safety, is collaborating with Rhode Island-based...

Press Release: eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

by Adam | Mar 24, 2020 | News

March 24, 2020 Niel, Belgium: eTheRNA Immunotherapies nv (‘eTheRNA’ or ‘The Company’), a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform, today announced that a consortium has been formed with North American and...

Providence biotech company working to create coronavirus vaccine – Providence NBC 10 News interview

by Adam | Mar 20, 2020 | News

Providence biotech company working to create coronavirus vaccine by TAMARA SACHARCZYK, NBC 10 NEWS Wednesday, March 18th 2020 Find the full story here EpiVax in Providence. (WJAR) A team of local scientists are on the front lines of a global pandemic as they race...